Episurf Medical Q2: Changed strategy – Redeye

Publicerad

Redeye has a neutral stance on Episurf Medical’s Q2 report as sales have yet to take off.
However, we see that its customer base is expanding nicely, and we argue that the most
interesting news relates to its changed strategy. We will return with a case review update
in which we dive deeper into the implications on the case.

https://www.redeye.se/research/922320/episurf-medical-q2-changed-strategy?utm_source=finwire&utm_medium=RSS

Redeye

Annons